CLINICAL_TRIALS
trial_result
· 2014-06-20
Clinical Trial Update: Safety and Efficacy of CC-10004 for Prurigo Nodularis [Phase 2]
Summary
Phase 2 trial evaluating CC-10004 for prurigo nodularis has completed, with safety and efficacy results reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospitals Cleveland Medical Center | Conditions: Prurigo Nodularis | Phase 2 | Status: COMPLETED | Results posted: 2014-06-20